Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: In a recently completed 3-year, randomized, double-blind study, denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor κB ligand, significantly increased bone mineral density and decreased new vertebral fractures in men receiving androgen deprivation thera...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Smith, Matthew R., Saad, Fred, Egerdie, Blair, Szwedowski, Maciej, Tammela, Teuvo L. J., Ke, Chunlei, Leder, Benjamin Z., Goessl, Carsten
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900763/
https://ncbi.nlm.nih.gov/pubmed/19836774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.08.048
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia